Target Engagement for Oxytocin: Dose Ranging Study
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of 8 doses of intranasal oxytocin or placebo on two
proposed measures of target engagement in brain. The targets are (1) the suppression of a
particular wave form (mu) on the electroencephalogram (EEG) while subjects observe a socially
relevant form of motion and (2) pupil dilation will subjects identify faces showing different
emotions.